[1] Bray F, Ferlay J, Soerjomataram I, et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA: Cancer J Clin, 2018, 368: 394-424.   doi: 10.3322/caac.21492
[2] Sakka M, Kunzelmann L, Metzger M, et al.  Cardiac dose-sparing effects of deep-inspiration breath-hold in left breast irradiation: Is IMRT more beneficial than VMAT?[J]. Strahlenther Onkol, 2017, 193(10): 800-811.   doi: 10.1007/s00066-017-1167-0
[3] Thomsen MS, Harrov U, Fledelius W, et al.  Inter-and intra-fraction geometric errors in daily image-guided radiotherapy of free-breathing breast cancer patients measured with continuous portal imaging[J]. Acta Oncol, 2014, 53(6): 802-808.   doi: 10.3109/0284186X.2014.905700
[4] Singla R, King S, Albuquerque K, et al.  Simultaneous-integrated boost intensity-modulated radiation therapy (SIB-IMRT) in the treatment of early-stage left-sided breast carcinoma[J]. Med Dosim, 2006, 31(3): 190-196.   doi: 10.1016/j.meddos.2005.11.001
[5] Popescu CC, Olivotto IA, Beckham WA, et al.  Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes[J]. Int J Radiat Oncol Biol Phys, 2010, 76(1): 287-295.   doi: 10.1016/j.ijrobp.2009.05.038
[6] Tortorelli G, Di MurroL, Barbarino R, et al.  Standard or hypofractionated radiotherapy in the postoperative treatment of breast cancer: a retrospective analysis of acute skin toxicity and dose inhomogeneities[J]. BMC Cancer, 2013, 13: 230-.   doi: 10.1186/1471-2407-13-230
[7] Limbergen EV, Rijnders A, der Schueren EV, et al.  Cosmetic evaluation of breast conserving treatment for mammary cancer. 2. A quantitative analysis of the influence of radiation dose, fractionation schedules and surgical treatment techniques on cosmetic results[J]. Radiother Oncol, 1989, 16(4): 253-267.   doi: 10.1016/0167-8140(89)90037-6
[8] Preston DL, Pierce DA, Shimizu Y, et al.  Effect of recent changes in atomic bomb survivor dosimetry on cancer mortality risk estimates[J]. Radiat Res, 2004, 162(4): 37-389.   doi: 10.1667/rr3232
[9] Bahig H, Roussin É, Yassa M, et al.  Partial kilovoltage cone beam computed tomography, complete kilovoltage cone beam computed tomography, and electronic portal images for breast radiation therapy: A dose-comparison study[J]. Pract Radiat Oncol, 2015, 5(5): e521-e529.   doi: 10.1016/j.prro.2015.02.009
[10] Yorke ED, Jackson A, Rosenzweig KE, et al.  Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study[J]. Int J Radiat Oncol Biol Phys, 2005, 63(3): 672-682.   doi: 10.1016/j.ijrobp.2005.03.026
[11] Marks LB, Bentzen SM, Deasy JO, et al.  Radiation dose-volume effects in the lung[J]. Int J Radiat Oncol Biol Phys, 2010, 76(3 Suppl): S70-S76.
[12] Abdel-Qadir H, Austin PC, Lee DS, et al.  A population-based study of cardiovascular mortality following early-stage breast cancer[J]. JAMA Cardio, 2017, 2(1): 88-93.   doi: 10.1001/jamacardio.2016.3841
[13] Jacobse JN, Duane FK, Boekel NB, et al.  Radiation dose response for risk of myocardial infarction in breast cancer survivors[J]. Int J Radiat Oncol Biol Phys, 2019, 103(3): 595-604.   doi: 10.1016/j.ijrobp.2018.10.025